Stéphane Chemouny

Certis Therapeutics SAS is a spinoff from IHU Liryc, a leading international institute focused on better understanding and treating cardiac electric disorders. Certis Therapeutics is based in Bordeaux, France, and was founded by Stéphane Chemouny, who has been the CEO since incorporation. The French company develops software and hardware devices to deliver thermal energy with unprecedented accuracy, which applies to radiofrequencies, microwaves, laser, and focused ultrasound thermal ablation. The company's core technology has been validated on various organs and addresses cardiology, oncology, and neurology.

EuroBioMed engages as an association related to healthcare research, engineering innovation and support for companies and projects. It operates in the following business segments: teaching, fundamental, translational and clinical research, technological innovation centers, start-ups and, industrial success stories. The company was founded in 2009 and is headquartered in Marseille, France.